TRT Nations approach to medical weight loss includes practical guidance to help you build sustainable habits alongside your treatment
The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI)
Contact your GP if you experience severe abdominal pain (which may indicate pancreatitis), persistent vomiting or diarrhoea, symptoms of gallbladder problems, recurrent hypoglycaemia, sudden vision changes, or any signs of urinary tract infection such as burning when urinating or cloudy urine
Retatrutide is an investigational injectable medication currently under clinical development for the treatment of obesity and type 2 diabetes
As global policymakers and healthcare advisers move to curb ultra-processed foods (UPFs), The Lancet has published a series outlining policy recommendations to regulate and reduce these products, underscoring that education and consumer-focused behavioral shifts are insufficient